(NASDAQ: STAA) Staar Surgical Co's forecast annual revenue growth rate of 11.14% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.78%.
Staar Surgical Co's revenue in 2026 is $290,375,000.On average, 13 Wall Street analysts forecast STAA's revenue for 2026 to be $16,995,800,653, with the lowest STAA revenue forecast at $15,540,482,944, and the highest STAA revenue forecast at $18,700,060,837. On average, 13 Wall Street analysts forecast STAA's revenue for 2027 to be $18,410,291,796, with the lowest STAA revenue forecast at $16,472,523,571, and the highest STAA revenue forecast at $20,315,199,615.
In 2028, STAA is forecast to generate $19,854,656,036 in revenue, with the lowest revenue forecast at $17,423,981,710 and the highest revenue forecast at $22,646,794,836.